Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | - USD | 100.0% |
| 2022 | -4.18 Million USD | -16.66% |
| 2021 | -3.58 Million USD | 15.89% |
| 2020 | -4.26 Million USD | -12448.82% |
| 2019 | -33.99 Thousand USD | -2732.67% |
| 2018 | -1200.00 USD | -445.45% |
| 2017 | -220.00 USD | 0.0% |
| 2014 | -90.98 Thousand USD | 11.88% |
| 2013 | -103.25 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2022 Q2 | -1.87 Million USD | -55.94% |
| 2022 Q1 | -1.2 Million USD | -91.95% |
| 2022 FY | -4.18 Million USD | -16.66% |
| 2022 Q4 | -167.72 Thousand USD | 82.03% |
| 2022 Q3 | -933.32 Thousand USD | 50.34% |
| 2021 FY | -3.58 Million USD | 15.89% |
| 2021 Q3 | -2.66 Million USD | -2693.06% |
| 2021 Q4 | -627.86 Thousand USD | 76.43% |
| 2021 Q2 | -95.36 Thousand USD | 52.61% |
| 2021 Q1 | -201.2 Thousand USD | 94.62% |
| 2020 FY | -4.26 Million USD | -12448.82% |
| 2020 Q4 | -3.74 Million USD | -721.36% |
| 2020 Q2 | -51.09 Thousand USD | -171.83% |
| 2020 Q1 | -18.79 Thousand USD | 22.91% |
| 2020 Q3 | -455.37 Thousand USD | -791.19% |
| 2019 Q4 | -24.38 Thousand USD | -170.69% |
| 2019 FY | -33.99 Thousand USD | -2732.67% |
| 2019 Q2 | -300.00 USD | 75.0% |
| 2019 Q1 | -1200.00 USD | 0.0% |
| 2019 Q3 | -9008.00 USD | -2902.67% |
| 2018 FY | -1200.00 USD | -445.45% |
| 2017 FY | -220.00 USD | 0.0% |
| 2015 Q3 | -1770.00 USD | 96.22% |
| 2015 Q1 | -122.48 Thousand USD | -120.93% |
| 2015 Q2 | -46.86 Thousand USD | 61.74% |
| 2014 Q1 | -29.54 Thousand USD | 14.16% |
| 2014 Q4 | -55.43 Thousand USD | -1021.11% |
| 2014 Q3 | -4945.00 USD | -368.28% |
| 2014 Q2 | -1056.00 USD | 96.43% |
| 2014 FY | -90.98 Thousand USD | 11.88% |
| 2013 Q4 | -34.41 Thousand USD | -382333.33% |
| 2013 FY | -103.25 Thousand USD | 0.0% |
| 2013 Q3 | -9.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 100.0% |
| Arrayit Corporation | -3.62 Million USD | 100.0% |
| Atlantic International Corp. | -5.73 Million USD | 100.0% |
| Biocept, Inc. | -31.98 Million USD | 100.0% |
| Bioqual, Inc. | -19.63 Thousand USD | 100.0% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 100.0% |
| DermTech, Inc. | -103.73 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 100.0% |
| iMD Companies, Inc. | -175.44 Thousand USD | 100.0% |
| IDenta Corp. | -1499.00 USD | 100.0% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 100.0% |
| InVitro International | -25.33 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 100.0% |
| Medical Imaging Corp. | -819.48 Thousand USD | 100.0% |
| NovelStem International Corp. | -3.52 Million USD | 100.0% |
| Optigenex Inc. | 1.39 Million USD | 100.0% |
| PharmChem, Inc. | 973.14 Thousand USD | 100.0% |
| Proteome Sciences plc | -1.62 Million USD | 100.0% |
| Response Genetics, Inc | -21.37 Million USD | 100.0% |
| Rennova Health, Inc. | -1.4 Million USD | 100.0% |
| RushNet, Inc. | -684.7 Thousand USD | 100.0% |
| ScreenPro Security Inc. | -2.59 Million USD | 100.0% |
| Stella Diagnostics Inc. | -11.42 Million USD | 100.0% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 100.0% |
| Todos Medical Ltd. | -9.74 Million USD | 100.0% |